BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4166582)

  • 1. Hyperthyroidism and demonstration of circulating long-acting thyroid stimulator following hypophysectomy for chromophobe adenoma.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1161-6. PubMed ID: 4166582
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acromegaly and parathyroid adenoma.
    Lamberg BA; Ripatti J; Gordin A; Juustila H; Sivula A; af Björkesten G
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):157-72. PubMed ID: 4308288
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 5. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 7. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.
    Shishiba Y; Solomon DH; Beall GN
    Endocrinology; 1967 May; 80(5):957-61. PubMed ID: 6023563
    [No Abstract]   [Full Text] [Related]  

  • 9. Case of hyperthyroidism due to a chromophobe adenoma.
    Baylis PH
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):145-50. PubMed ID: 1269160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma.
    Hamilton CR; Adams LC; Maloof F
    N Engl J Med; 1970 Nov; 283(20):1077-80. PubMed ID: 5470849
    [No Abstract]   [Full Text] [Related]  

  • 12. IMMUNOLOGICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    DORRINGTON KJ; MUNRO DS
    Clin Sci; 1965 Feb; 28():165-74. PubMed ID: 14256898
    [No Abstract]   [Full Text] [Related]  

  • 13. ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.
    KRISS JP; PLESHAKOV V; CHIEN JR
    J Clin Endocrinol Metab; 1964 Oct; 24():1005-28. PubMed ID: 14228525
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyrotoxicosis from molar thyrotropin.
    Karp PJ; Hershman JM; Richmond S; Goldstein DP; Selenkow HA
    Arch Intern Med; 1973 Sep; 132(3):432-6. PubMed ID: 4361214
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-specific responses in the assay of thyrotrophin and long-acting thyroid stimulator.
    Adams DD; Kennedy TH; Purves HD
    Aust J Exp Biol Med Sci; 1966 Aug; 44(4):355-64. PubMed ID: 5967342
    [No Abstract]   [Full Text] [Related]  

  • 18. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T; Kotani M; Yamada T; Ochi Y
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid eye disease and its relationship to the long-acting thyroid stimulator.
    Hollows FC; Beaumont P
    Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318
    [No Abstract]   [Full Text] [Related]  

  • 20. [New knowledge about the pathogenesis of hyperthyroidism].
    Küchel O; Horký K
    Cas Lek Cesk; 1969 Jul; 108(28):833-8. PubMed ID: 4978076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.